Amylyx Pharmaceuticals, Inc.

AMLX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$20.17-0.69%

2026-08-03

Financials

Valuation Metrics

Amylyx Pharmaceuticals, Inc.'s Market Cap is $2.24B. At end of 2025 it was $1.14B. Ranked #1973 of 3,112 in US market (top 63%), #743 of 1,445 on NASDAQ (top 51%), #124 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 46%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$2.24B	US#1,973/3,112 Sec#124/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-150M	US—/3,112 Sec—/269
Total Assets	$294M	US#2,902/3,112 Sec#214/269
Net Assets	$273M	US#2,599/3,112 Sec#170/269
Value
P/B	8.21x	US#2,507/3,112 Sec#192/269
FCF Yield	-5.37%	US—/3,112 Sec—/269
Profitability
ROE	-54.95%	US#2,759/3,112 Sec#183/269
ROA	-51.13%	US#2,969/3,112 Sec#218/269
Revenue Growth	-100.00%	US#2,948/3,112 Sec#190/269
Financial Health
Debt Ratio	7.48%	US#73/3,112 Sec#33/269
Total Debt	$6M	US#2,840/3,112 Sec#215/269
FCF	$-121M	US#2,626/3,112 Sec#167/269
Cash	$229M	US#1,622/3,112 Sec#102/269
Current Ratio	17.85x	US#142/3,112 Sec#41/269
Performance
1Y Return	161.27%	US#154/3,112 Sec#49/269
1M Return	10.40%	US#508/3,112 Sec#21/269
From 52W High	-3.68%	US#412/3,112 Sec#14/269
1Y MDD	-30.61%	US#1,434/3,112 Sec#88/269
Trading
Volume	1,589,691 shares	US#1,073/3,112 Sec#96/269
Trading Value	$32M	US#1,683/3,112 Sec#114/269
Per Share
EPS	$-1.53	US—/3,112 Sec—/269
BPS	$3.23	US#2,400/3,112 Sec#157/269